suPARnostic® Measures suPAR

suPAR is a protein in the blood. If an individual’s suPARnostic® level is very high, there is an increased chance of negative outcome (e.g. mortality) if appropriate treatment is not administered at the earliest. Appropriate treatment should result in a lowered suPARnostic® level.
Read more...
 

suPARnostic® as Marker for Immune Activation       

In April 2006, the crystal structure of suPAR was published in Science.  The three domain structure was shown to be able to differentially rotate around its main axis to accommodate a number of complex ligands. 
Read more...
 

Measuring & Understanding suPARnostic®

Our numerous research studies show that at suPARnostic® measurements between 0.1 to 4.0 nanograms per millilitre (ng/mL), a patient can be considered healthy, with no challenges to the immune system and no signs or symptoms of an opportunistic infection or inflammation.
Read more...
 

suPAR in Clinical Settings

suPAR levels are thought to reflect the state of immune activation of the individual. This is substantiated by findings of increased suPAR levels in diseased individuals suffering from viral, bacterial or parasitical infections as well as autoimmune diseases and cancer.
Read more...
 

suPARnostic® - Patient Priority & Prognosis

suPARnostic®’s powerful prognostic value is exhibited in extensive research which shows that high suPAR levels reflect increased inflammation and critical immune activation. suPAR’s high stability and uniform kinetics make it a reliable clinical biomarker.
Read more...
 

Testimonials

S. aureus suPAR data - interesting results!

"I must admit that I am quite astonished - even excited on the data. There really seems to be a point even though we have tried to control the analysis by all possible means."

- Asko Järvinen, MD, PhD, Chief Physician, Senior Lecturer, Division of Infectious Diseases, Helsinki University Hospital. March 2010.

 

 

suPARnostic® Compared to Other Biomarkers

suPARnostic® is a truly novel biomarker – not only in the sense of a novel protein used as a marker, but also in the concept of applying the information gained from that measurement: suPARnostic® is a true prognostic marker – without a diagnostic link to any particular disease.
Read more...
 

News

suPARnostic® test now part of screening program at Hvidovre University Hospital

Novel screening program prevents admissions to the hospital.... 

 

suPARnostic® partnered with new distributors in France, India and Ireland....     


 

"suPAR - en helt ny måde at tænke sygdom på"
Read the article in the magazine Praksis.....                                                           

 

"Dansk opfindelse kan fange sygdomssignaler i opløbet"
Read the article from Opfinderrådgivningen, Teknologisk Institut...                                                                    

 

ViroGates launches suPARnostic® Quick Triage product
Read more about this new marker for the emergency room
....                                                                                 

 


Follow suPAR on Twitter:

suPARnostic®

Find suPAR on LinkedIn:

suPARnostic®